RT Journal Article
SR Electronic
T1 An easy, reliable and rapid SARS-CoV2 RT-LAMP based test for Point-of-Care and diagnostic lab
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.25.20200956
DO 10.1101/2020.09.25.20200956
A1 Gouilh, Meriadeg AR
A1 Cassier, Renaud
A1 Maille, Elodie
A1 Schanen, Cécile
A1 Rocque, Louis-Marie
A1 Vabret, Astrid
YR 2020
UL http://medrxiv.org/content/early/2020/09/25/2020.09.25.20200956.abstract
AB This study presents and evaluates a rapid and all-in-one SARS-CoV-2 RT-LAMP based molecular detection system, including RNA extraction or not, for point-of-care or massive testing of naso-pharyngeal swabs. The point-of-care format uses LoopX©, a small portative device ensuring optimal LAMP reaction and automated reading with 95.2% and 95.5% sensitivity and specificity respectively. This system might also be useful for testing other sample types such as saliva.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe funders has no role in the design of the study. This study has been funded by the Agence Innovation de Défense (French Defence Innovation Agency) and the DGA Maitrise NRBC (Armament General Directorate CBRN Defence Center), CHU de Caen and Loop Dee Science.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB that provided approval for the research described : CPP SUD MEDITERRANEE V, Ref CNRIPH 20.04.10.37320 All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in the present study are available upon request.